Supplements · Metabolic & Cardiometabolic

green tea decreases cardiovascular mortality

In plain terms: Does green tea protect your heart / help you live longer?

Leans support(causal-association-only) Supplements 🔬 Includes disconfirming🔎 Limited evidence — fewer than 12 studies

RefutedContestedStrong support

consensus score 0.68

🔬 Capped to leans support — causal-association-only evidence only. The raw signal looked like strong support, but a claim about human health can't be graded that high on animal or lab evidence alone. It stays capped until human trials weigh in.

Maybe, maybe not. Big Asian studies link green tea drinkers to lower heart-disease deaths — but those people are healthier in general, and a genetics-based study that strips out that confounding found no actual causal effect. Promising association, not proven cause.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

7 support 1 contradict 1 tested null 0 mixed · 9 sources, 7 independent groups

What the evidence shows

Large Japanese/Asian cohorts consistently link higher green tea intake to lower cardiovascular and all-cause mortality — but this is OBSERVATIONAL (green-tea drinkers are healthier overall), the data barely generalize beyond Asia, and a Mendelian-randomization study (which is far less prone to confounding) found NO causal effect on heart disease or stroke. Association, not established causation.

Cochrane has no ruling yet see how our grade compares ▾

Cochrane review 2013 · not stated Not directly comparable

GRADE not applied); trials judged small, short-term, moderate-to-poor quality

“There are very few long-term studies to date examining green or black tea for the primary prevention of CVD. The limited evidence suggests that tea has favourable effects on CVD risk factors, but due to the small number of trials contributing to each analysis the results should be treated with some caution and further high quality trials with longer-term follow-up are needed to confirm this.”

Not directly comparable: their review asks a different question or reports an outcome we do not grade, so it neither corroborates nor contradicts this claim.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (9)

Source	Grade	Stance	Quality	Finding
Le NT et al 2026 · study_type: observational	observational	supports	moderate	Hanoi Prospective Cohort Study, 42,146 Vietnamese adults, median 11-year follow-up, 2494 deaths; green tea intake inversely associated with all-cause mortality (HR per SD = 0.93, 95% CI 0.89-0.97), significant in males but not females.
Kuriyama S 2008 · J Nutr	observational	supports	moderate	Ohsaki follow-up review: green tea inversely associated with CVD mortality (HR 0.69, women), stronger for stroke. (Same Ohsaki cohort/group as Kuriyama 2006.)
Chung M et al. 2020 · Adv Nutr	meta-analysis	supports	moderate	Meta 39 cohorts: each cup/day tea ~4% lower CVD mortality; evidence low-to-moderate, larger effects in lower-quality studies.
Liang S et al. 2024 · Medicine (Baltimore)	observational	contradicts	moderate	Mendelian-randomization (Europeans + East Asians): NO causal association between genetically-predicted green tea and atrial fibrillation, heart failure, stroke, or coronary artery disease (all OR ~1.0) - undercuts the cohort signal.
Kim TL et al. 2024 · Epidemiol Health	meta-analysis	supports	moderate	Meta 38 cohorts: tea inversely associated with all-cause and CVD mortality; heterogeneity across tea types/regions.
Tang J et al. 2015 · Br J Nutr	meta-analysis	supports	moderate	Meta 18 prospective cohorts: highest vs lowest green tea - CVD mortality RR 0.67, all-cause RR 0.80; ~5%/cup lower CVD mortality.
Liu D et al. 2021 · Zhonghua Xin Xue Guan Bing Za Zhi	observational	supports	low	Dose-response meta (1.3M subjects): >=1 cup/d tea - CVD mortality RR 0.86; green-tea subgroup -15% (general+green tea).
Kuriyama S et al. 2006 · JAMA	observational	supports	high	Ohsaki cohort (n=40,530, Japan): >=5 cups/d vs low - all-cause mortality HR 0.84; CVD mortality HR 0.74 in women (weaker/null in men).
Igho-Osagie E et al. 2020 · J Nutr	meta-analysis	tested-null	moderate	Meta 14 RCTs (n=798): short-term green/black tea NO effect on BP or lipids - undercuts the proposed causal pathway.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.